Switch to:
More From Other Websites
BioTime, Inc.’s Subsidiary OncoCyte Corporation’s CEO Dr. Joseph Wagner to Present at BTIG’s... Sep 19 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 19 2014
9:03 am BioTime's aubsidiary Cell Cure Neurosciences demonstrates the safety and efficacy of OpRegen... Sep 17 2014
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates the Safety and Efficacy of... Sep 17 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 17 2014
BIOTIME INC Files SEC form 8-K, Other Events Sep 15 2014
BioTime, Inc.’s Subsidiary OncoCyte Corporation and Abcodia to Collaborate on Breast Cancer... Sep 15 2014
BioTime, Inc.’s Subsidiary OncoCyte Corporation and Abcodia to Collaborate on Breast Cancer... Sep 15 2014
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement Sep 11 2014
BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology... Sep 11 2014
BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology... Sep 11 2014
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial... Sep 11 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 10 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Sep 09 2014
BioTime CEO Dr. Michael D. West to Present at Rodman & Renshaw 16th Annual Healthcare Conference Sep 09 2014
Asterias Biotherapeutics Announces Record Date for Distribution of BioTime Warrants to Holders of... Sep 04 2014
BioTime's AST-OPC1 Cleared by FDA for Phase I/IIa Study Aug 28 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Aug 28 2014
BioTime to Collaborate With the University of Wisconsin and Louvain University in Test of... Aug 28 2014
BioTime Subsidiary Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a... Aug 27 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK